Arrayit Opens New Diagnostics Marketing Division | GenomeWeb

NEW YORK (GenomeWeb News) – Sunnyvale, Calif.-based Arrayit is opening a business based in Houston that will serve as a commercial arm for diagnostics that will run on the company's microarray platform.

The Arrayit Diagnostics subsidiary will promote and market tests using the microarray platform that are aimed at early-stage diagnostics. Arrayit currently is developing diagnostic tests for cancer, neurodegenerative disease, and other diseases.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.